Sequence Similarity Clusters for the Entities in PDB 1RZ7

Entity #1 | Chains: L
Fab 48d light chain protein, length: 212 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 4 16716
95 % 1 5 10072 Flexibility: Low
Max RMSD: 6.5, Avg RMSD: 2.2
PDBFlex
90 % 194 761 2
70 % 593 2516 1
50 % 1223 5101 1
40 % 1441 5750 1
30 % 1759 7168 1
Entity #2 | Chains: H
Fab 48d heavy chain protein, length: 219 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 4 16507
95 % 1 5 10047
90 % 1 5 9918
70 % 593 2475 2
50 % 1224 5101 1
40 % 1442 5750 1
30 % 1760 7168 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 4NZU 1 L 13PL heavy chain Fab 9606
10 4NZU 2 H 13PL light chain Fab 9606
11 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
12 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
13 5IMM 1 B Nanobody 9835
14 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
15 5NLU 1 A single domain llama antibody Nb36 9844
16 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 1MEX 1 L Fab 29G12 light chain 10090
19 1MEX 2 H Fab 29G12 heavy chain 10090
20 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
21 5IMK 1 B Nanobody 9835
22 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
23 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
25 4BUH 1 A, B CLONE M0418 SCFV 9606
26 4B50 1 A 2H10 LLAMA VHH 9844
27 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
28 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
29 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
30 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
31 2XT1 2 B CAMELID VHH 9 30538
32 5UD9 1 H Fab heavy chain 9606
33 5UD9 2 L Light chain 9606
34 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
35 4P48 1 A Antibody scFv 180 9031
36 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
37 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
38 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
39 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
40 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
41 5J1S 3 C VHH domain BS-2 30538
42 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
43 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
44 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
45 5J1T 3 C VHH domain BS-2 30538
46 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
47 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
48 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
49 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
50 4XCF 1 L 4E10 Fab light chain 9606
51 4XCF 2 H 4E10 Fab heavy chain 9606
52 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
53 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
54 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
55 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
56 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
57 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
58 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
59 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
60 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
61 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
62 5X08 1 H Fab 4E10 Heavy chain 9606
63 5X08 2 L Fab 4E10 Light chain 9606
64 2X1O 1 A, B GELSOLIN NANOBODY 9844
65 4QGY 1 A, B nanobody n25, VH domain 9844
66 5C2B 1 H scFv 3B4 heavy chain 9606
67 4XAW 1 L 4E10 Fab light chain 9606
68 4XAW 2 H 4E10 Fab heavy chain 9606
69 5VNV 1 A Nb.b201 32630
70 4P49 1 A Antibody scFv B8 9031
71 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
72 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
73 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
74 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
75 5DXW 1 A PD-L1 nanobody 10090
76 5UCB 1 H Fab Heavy Chain 9606
77 5UCB 2 L Fab Light Chain 9606
78 2VXV 1 H HUMAN IGG ABT-325 9606
79 2VXV 2 L HUMAN IGG ABT-325 9606
80 4N9O 2 B Nanobody Nb484 Nb484 9844
81 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
82 4GXV 1 H, I Antibody 1F1, heavy chain 9606
83 4GXV 2 L, M Antibody 1F1, light chain 9606
84 2VXT 1 H MURINE IGG 125-2H 10090
85 2VXT 3 L MURINE IGG 125-2H 10090
86 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
87 1T2J 1 A M12-Variable Heavy domain 9606
88 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
89 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
90 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
91 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
92 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
93 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
94 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
95 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
96 5W24 1 L 5C4 Fab Light Chain 10090
97 5W24 2 H 5C4 Fab Heavy Chain 10090
98 4HPY 1 H CH59 Fab heavy chain 9606
99 4HPY 2 L CH59 Fab light chain 9606
100 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
101 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
102 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
103 5VM6 1 A single domain camelid nanobody VHH T10 9844
104 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
105 4JG1 1 L Fab light chain 9606
106 4JG1 2 H Fab heavy chain 9606
107 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
108 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
109 4KML 2 B Nanobody 9844
110 5VF2 1 A scFv 2D10 10090
111 5I8C 1 A VRC34.01 Fab heavy chain 9606
112 5I8C 2 B VRC34.01 Fab light chain 9606
113 4O5L 1 L Fab F045-092 light chain 9606
114 4O5L 2 H Fab F045-092 heavy chain 9606
115 5MYX 1 A, C Fab c#24 light chain 10090
116 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
117 4Z9K 2 B VHH2(F5) antibody 30538
118 3IFL 1 L 12A11 FAB antibody light chain 10090
119 3IFL 2 H 12A11 FAB antibody heavy chain 10090
120 5WK2 1 L M116 LIGHT CHAIN 9606
121 5WK2 2 H M116 HEAVY CHAIN FD 9606
122 3PP4 1 H GA101 Fab heavy chain 10090
123 3PP4 2 L GA101 Fab light chain 10090
124 3KDM 1 A, L Immunoglobulin light chain 9606
125 3KDM 2 B, H Immunoglobulin heavy chain 9606
126 5NIV 1 A Light chain of 5D3 Fab 10090
127 5NIV 2 B Heavy chain of 5D3 Fab 10090
128 5N4J 1 L LIGHT CHAIN 9606
129 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
130 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
131 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
132 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
133 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
134 5X4G 1 A 6H8 Fab heavy chain 10090
135 5X4G 2 B 6H8 Fab light chain 10090
136 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
137 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
138 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
139 4PTU 1 A Antibody pn132p2C05, light chain 9606
140 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
141 4TPR 1 L If kappa light chain 10090
142 4TPR 2 H Fab heavy chain 10090
143 5LMW 1 A Nanobody 9844
144 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
145 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
146 3IFN 1 H 12A11 FAB antibody heavy chain 10090
147 3IFN 2 L 12A11 FAB antibody light chain 10090
148 5U3P 1 H DH511.4 Fab Heavy Chain 9606
149 5U3P 2 L DH511.4 Fab Light Chain 9606
150 6BLA 1 H AMM01 Fab Heavy chain 9606
151 6BLA 2 L AMM01 Fab Light chain 9606
152 5NM0 1 A, B, C, D Nb36 9844
153 4TOY 1 H 35O22 Fab Heavy chain 9606
154 4TOY 2 L 35O22 Fab Light chain 9606
155 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
156 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
157 3NPS 2 B S4 FAB HEAVY CHAIN 9606
158 3NPS 3 C S4 FAB LIGHT CHAIN 9606
159 5I4F 1 A scFv 2D10 10090
160 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
161 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
162 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
163 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
164 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
165 5WN9 1 H scFv 2D10 9606
166 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
167 4XC3 1 L 4E10 Fab light chain 9606
168 4XC3 2 H 4E10 Fab heavy chain 9606
169 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
170 4PPT 1 A Engineered single domain VHH antibody 9844
171 3R0M 1 A, B Llama VHH A12 9844
172 4M5Y 1 H, I Fab 5J8 heavy chain 9606
173 4M5Y 2 L, M Fab 5J8 light chain 9606
174 4TQE 1 L If kappa light chain 10090
175 4TQE 2 H Fab heavy chain 10090
176 3ZKQ 2 D XA4813 9844
177 4I13 2 B Protein ca1697 (nanobody) 9844
178 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
179 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
180 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
181 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
182 5C2U 1 B Nanobody Nanobody 9838
183 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
184 5VSI 2 L CH1/Ckappa Fab light chain 9606
185 1XFP 1 A heavy chain antibody VHH domain 9838
186 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
187 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
188 5JXA 1 H VRC03 Heavy chain 9606
189 5JXA 2 L VRC03 Light chain 9606
190 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
191 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
192 4POY 1 A VHH-metal 9844
193 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
194 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
195 5NLW 1 A nanobody Nb36 9844
196 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
197 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
198 3NTC 1 L Fab light chain 10090
199 3NTC 2 H Fab heavy chain 10090
200 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
201 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
202 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
203 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
204 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
205 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
206 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
207 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
208 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
209 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
210 6BE3 1 H Fab (F598) Heavy Chain 9606
211 6BE3 2 L Fab (F598) Light Chain 9606
212 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
213 3G9A 2 B Minimizer 9838
214 4NWU 1 H APE1551 Ab Fab heavy chain 9606
215 4NWU 2 L APE1551 Ab Fab light chain 9606
216 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
217 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
218 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
219 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
220 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
221 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
222 5EWI 1 H VRC38.01 Heavy Chain 9606
223 5EWI 2 L VRC38.01 Light Chain 9606
224 5E2W 1 L AT8 LIGHT CHAIN 10090
225 5E2W 2 H AT8 HEAVY CHAIN 10090
226 5MYK 1 A Fab c#17 light chain 10090
227 5MYK 2 B Fab c#17 heavy chain 10090
228 4NZR 1 H PGT135 heavy chain Fab 9606
229 4NZR 2 L PGT135 light chain Fab 9606
230 5MYO 1 A, C Fab c#6 light chain 10090
231 5MYO 2 B, D Fab c#6 heavy chain 10090
232 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
233 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
234 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
235 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
236 5UEL 1 H 354NC102 Fab Heavy Chain 9606
237 5UEL 2 L 354NC102 Fab Light Chain 9606
238 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
239 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
240 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
241 2P43 2 B ANTIBODY CAB-RN05 9838
242 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
243 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
244 5E2V 1 L AT8 LIGHT CHAIN 10090
245 5E2V 2 H AT8 HEAVY CHAIN 10090
246 4KRN 1 A Nanobody/VHH domain EgA1 9844
247 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
248 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
249 4GFT 2 B Nanobody 9844
250 4TVS 2 a, b VHH Domain BS-1 30538
251 4W6Y 2 B Nanobody NbFedF9 9844
252 6EZW 1 B VHH antibody BCD090-M2 9844
253 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
254 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
255 5JUE 1 L light chain of UIC2 Fab 10090
256 5JUE 2 H heavy chain of UIC2 Fab 10090
257 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
258 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
259 1UAC 2 H Ig VH,anti-lysozyme 10090
260 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
261 5JR1 1 H 10E8 heavy chain 9606
262 5JR1 2 L 10E8 mature light chain 9606
263 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
264 5VF6 1 A single chain variable fragment 9031
265 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
266 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
267 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
268 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
269 5OB5 2 H fAb Heavy chain 9606
270 5OB5 3 L fAb Light chain 9606
271 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
272 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
273 5I66 1 A 8B6 antibody, heavy chain 10090
274 5I66 2 B 8B6 antibody, light chain 10090
275 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
276 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
277 3QQ9 1 C, L 101F LIGHT CHAIN 10090
278 3QQ9 2 D, H 101F HEAVY CHAIN 10090
279 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
280 5TKK 3 L mouse antibody vFP5.01 light chain 10090
281 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
282 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
283 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
284 5W6C 1 H UCA Fab heavy chain 9606
285 5W6C 2 L UCA Fab light chain 9606
286 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
287 5I1K 1 L FAB LIGHT CHAIN 9606
288 5I1K 2 H FAB HEAVY CHAIN 9606
289 3OZ9 1 L Fab NC-1 kappa light chain 10090
290 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
291 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
292 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
293 5V7U 1 L CBTAU-22.1 Fab light chain 9606
294 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
295 5UEA 1 A, H Fab Heavy Chain 9606
296 5UEA 3 B, L Fab Light Chain 9606
297 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
298 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
299 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
300 3G5Y 1 A 175 light chain 10090
301 3G5Y 2 B 175 heavy chain 10090
302 5O02 2 C Nanobody (VHH) Nano-4 30538
303 5NMV 1 L Fab light chain 10088
304 5NMV 2 H Fab heavy chain 10088
305 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
306 4N8C 2 L, M Light chain of monoclonal antibody 10090
307 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
308 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
309 4HGW 1 A Antibody Fab fragment, light chain 10090
310 4HGW 2 B Antibody Fab fragment, heavy chain 10090
311 1NLB 1 L antibody 19D9D6 light chain 10090
312 1NLB 2 H antibody 19D9D6 heavy chain 10090
313 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
314 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
315 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
316 3VFG 1 L 3F8 Light Chain 10090
317 3VFG 2 H 3F8 Heavy Chain 10090
318 4X7F 2 C, D Nano-25 Nanobody 30538
319 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
320 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
321 3QRG 1 L Fab light chain 9606
322 3QRG 2 H Fab heavy chain Fd fragment 9606
323 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
324 5M6A 1 A, B, C, D Bence-Jones light chain 9606
325 4LLY 2 B, D light chain Clambda 9606
326 4LGR 2 B Camelid nanobody (VHH3) 30538
327 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
328 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
329 5EZI 1 H Fab c12 heavy chain 9606
330 5EZI 2 L Fab c12 Light chain 9606
331 4K23 1 H anti-uPAR antibody, heavy chain 10090
332 4K23 2 L anti-uPAR antibody, light chain 10090
333 5J57 2 B VHH single chain antibody V5E1 30538
334 3NCJ 1 L Fab15 Mut8 light chain 9606
335 3NCJ 2 H Fab15 Mut8 heavy chain 9606
336 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
337 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
338 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
339 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
340 5W05 1 L M59 FAB LIGHT CHAIN 10090
341 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
342 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
343 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
344 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
345 5OMM 2 C Nanobody (VHH) Nano-14 30538
346 5E03 1 A mouse CTLA-4 nanobody 10090
347 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
348 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
349 4M61 1 A, C Fab A52 light chain 10090
350 4M61 2 B, D Fab A52 heavy chain 10090
351 5LZ0 1 A, B PorM nanobody 9844
352 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
353 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
354 1UM5 1 L Antibody 21H3 L chain 10090
355 1UM5 2 H Antibody 21H3 H chain 10090
356 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
357 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
358 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
359 4NWT 1 L APE1531 Ab Fab light chain 9606
360 4NWT 2 H APE1531 Ab Fab heavy chain 9606
361 3WHX 1 A mAb Fab H fragment 10090
362 3WHX 2 B mAb Fab L fragment 10090
363 3NA9 1 L Fab15 light chain 9606
364 3NA9 2 H Fab15 heavy chain 9606
365 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
366 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
367 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
368 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
369 4LRI 1 A, B MSL-109 Light Chain 9606
370 4LRI 2 C, P MSL-109 Heavy Chain 9606
371 2XXC 1 B CAMELID VHH 9 30538
372 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
373 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
374 4JN2 1 A, L anti dabigatran Fab 10090
375 4JN2 2 B, H anti dabigatran Fab 10090
376 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
377 4XBE 2 H 4E10 Fab heavy chain 9606
378 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
379 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
380 6BE2 1 H Fab (F598) Heavy Chain 9606
381 6BE2 2 L Fab (F598) Light Chain 9606
382 3QYC 1 A, B VH domain of IgG molecule 9606
383 4JFZ 1 L Fab light chain 9606
384 4JFZ 2 H Fab heavy chain 9606
385 5VAK 2 B Nb914 Nanobody 9844
386 3WIF 1 A mAb Fab H fragment 10090
387 3WIF 2 B mAb Fab L fragment 10090
388 5U6A 1 A Light Chain 9606
389 5U6A 2 B Heavy Chain 9606
390 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
391 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
392 3MBX 1 L X836 LIGHT CHAIN 10090
393 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
394 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
395 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
396 2XXM 2 B CAMELID VHH 9 30538
397 6APC 1 H Epididymis luminal protein 214 9606
398 6APC 2 L IGL@ protein 9606
399 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
400 4HHA 1 A Fab KE5 Fab fragment KE5 9606
401 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
402 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
403 4RGO 2 H 14G8 heavy chain Fab 10090
404 4RGO 3 L 14G8 light chain Fab 10090
405 5GRY 1 A, G diabody 9606
406 5UEK 2 H Fab 12E Heavy Chain 9606
407 5UEK 3 L Fab 12E Light Chain 9606
408 3NAA 1 L Fab15 Mut5 light chain 9606
409 3NAA 2 H Fab15 Mut5 heavy chain 9606
410 1Q0X 1 L Fab 9B1, light chain 10090
411 1Q0X 2 H Fab 9B1, heavy chain 10090
412 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
413 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
414 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
415 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
416 5JDS 1 B Nanobody 9835
417 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
418 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
419 5IK3 2 B, D 1E03 Fab fragment light chain 9606
420 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
421 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
422 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
423 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
424 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
425 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
426 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
427 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
428 4WUK 1 H CH65 heavy chain 9606
429 4WUK 2 L CH65 light chain 9606
430 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
431 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
432 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
433 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
434 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
435 5JOP 1 D, L Fab 14.22 light chain 10090
436 5JOP 2 E, H Fab14.22 heavy chain 10090
437 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
438 4HPO 1 H CH58 Fab heavy chain 9606
439 4HPO 2 L CH58 Fab light chain 9606
440 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
441 5UKN 2 L DH522UCA Fab fragment light chain 9544
442 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
443 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
444 5L21 2 B VHH-C2 30538
445 5IT2 1 H heavy chain 9606
446 5IT2 2 L light chain 9606
447 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
448 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
449 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
450 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
451 5FWO 1 A NANOBODY 9844
452 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
453 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
454 5MO3 3 L Fab of monoclonal antibody, light chain 10090
455 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
456 5GZ0 1 A, C FM329 light chain 1383439
457 5GZ0 2 B, D FM329 heavy chain 1383439
458 3B9V 1 A, B, C, D heavy chain variable domain 9606
459 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
460 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
461 6BQB 1 L MGG4 Fab light chain 9606
462 6BQB 2 H MGG4 Fab heavy chain 9606
463 4PUB 1 H DX-2930 HEAVY CHAIN 9606
464 4PUB 2 L DX-2930 LIGHT CHAIN 9606
465 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
466 6B14 2 L Light chain of Fab BL3-6S97N 10090
467 5N88 1 A, H VH59 antibody 9606
468 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
469 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
470 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
471 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
472 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
473 5GS3 1 A, H diabody protein 9606
474 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
475 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
476 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
477 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
478 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
479 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
480 5VKD 2 H Fab Heavy Chain 9606
481 5VKD 3 L Fab light chain 9606
482 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
483 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
484 5XHG 1 A, C polypeptide(L) 562
485 5XHG 2 B, D polypeptide(H) 562
486 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
487 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
488 3UYR 1 H antibody Fab heavy chain 10090
489 3UYR 2 L antibody Fab light chain 10090
490 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
491 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
492 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
493 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
494 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
495 3OAZ 2 K, L Fab 2G12, light chain 9606
496 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
497 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
498 1ZAN 1 L Fab AD11 Light Chain 10116
499 1ZAN 2 H Fab AD11 Heavy Chain 10116
500 4N0Y 1 H IGH526 Heavy Chain 9606
501 4N0Y 2 L IGH526 Light Chain 9606
502 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
503 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
504 5MTH 1 A, H antibody Fab heavy chain 10090
505 5MTH 2 B, L antibody Fab light chain 10090
506 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
507 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
508 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
509 1RZF 1 L Fab E51 light chain 9606
510 1RZF 2 H Fab E51 heavy chain 9606
511 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
512 4KTE 2 L GE148 Light Chain Fab 9544
513 5I8O 1 H HMM5 antibody heavy chain 9606
514 5I8O 2 L HMM5 antibody light chain 9606
515 4OUO 1 A anti Bla g 1 scFv 9031
516 4JG0 1 L Fab light chain 9606
517 4JG0 2 H Fab heavy chain 9606
518 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
519 4YGV 2 B, L aDabi-Fab2a light chain 9606
520 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
521 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
522 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
523 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
524 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
525 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
526 3EO0 1 A, C GC-1008 Fab Light Chain 10090
527 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
528 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
529 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
530 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
531 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
532 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
533 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
534 4POU 2 B VHH Antibody 9844
535 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
536 4FQI 3 H antibody CR9114 heavy chain Fab 9606
537 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
538 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
539 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
540 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
541 4JHA 2 L D25 light chain 9606
542 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
543 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
544 4PTT 1 A Antibody pn132p2C05, light chain 9606
545 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
546 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
547 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
548 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
549 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
550 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
551 2P42 2 B, D ANTIBODY CAB-RN05 9838
552 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
553 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
554 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
555 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
556 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
557 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
558 4DGV 1 H HCV1 Heavy Chain Fab 9606
559 4DGV 2 L HCV1 Light Chain 9606
560 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
561 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
562 5TH2 1 A, C cetuximab Fab, light chain 10090
563 5TH2 2 B, D cetuximab Fab, heavy chain 10090
564 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
565 5I8K 1 L HHH1 Fab Light chain 9606
566 5I8K 2 H HHH1 Fab Heavy chain 9606
567 4QLR 1 A, B Llama nanobody n02 VH domain 9844
568 5J56 2 B VHH single chain antibody V1C7 30538
569 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
570 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
571 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
572 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
573 1YNL 1 L Ig gamma light chain 10090
574 1YNL 2 H Ig gamma heavy chain 10090
575 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
576 5EPM 2 B, F Antibody Fab fragment light chain 10090
577 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
578 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
579 3UMT 1 A scFv heavy chain and light chain 10090
580 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
581 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
582 4NUJ 1 A PGT152 light chain 9606
583 4NUJ 2 B PGT152 heavy chain 9606
584 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
585 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
586 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
587 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
588 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
589 3U2S 2 B, L PG9 light chain 9606
590 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
591 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
592 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
593 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
594 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
595 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
596 4NUG 1 L PGT151 light chain 9606
597 4NUG 2 H PGT151 heavy chain 9606
598 3IU4 1 H chP3 Fab heavy chain 10090
599 3IU4 2 L chP3 Fab light chain 10090
600 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
601 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
602 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
603 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
604 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
605 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
606 1P7K 1 A, L antibody light chain FAB 10090
607 1P7K 2 B, H antibody heavy chain FAB 10090
608 4NBX 2 B A20.1 VHH 9844
609 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
610 3RVV 2 C 4C1 - light chain 10090
611 3RVV 3 D 4C1 - heavy chain 10090
612 4HEP 2 G vHH17 domain 9844
613 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
614 3P0Y 2 H Fab DL11 heavy chain 9606
615 3P0Y 3 L Fab DL11 light chain 9606
616 4NPY 1 A, L germline PGT121 light chain Fab 9606
617 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
618 6ANA 2 H LL2 Fab Heavy Chain 10090
619 6ANA 3 L LL2 Fab Light Chain 10090
620 5IBU 1 B, L 6652 Light Chain 9606
621 5IBU 2 G, H 6652 Heavy Chain 9606
622 5VPL 2 C 4C1 - LIGHT CHAIN 10090
623 5VPL 3 D 4C1 - HEAVY CHAIN 10090
624 6AOD 1 A FXIa Antibody FAB Light Chain 9606
625 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
626 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
627 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
628 2YPV 2 H FAB 12C1 10090
629 2YPV 3 L FAB 12C1 10090
630 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
631 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
632 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
633 4JY5 1 L PGT122 light chain Fab 9606
634 4JY5 2 H PGT122 heavy chain Fab 9606
635 6ELE 1 A, H fAB heavy chain 9606
636 6ELE 2 B, L fAB light chain 9606
637 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
638 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
639 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
640 6B5R 1 H CIS42 Fab Heavy chain 9606
641 6B5R 2 L CIS42 Fab Light chain 9606
642 5IML 2 B Nanobody 9835
643 3NAC 1 L Fab15 Mut7 light chain 9606
644 3NAC 2 H Fab15 Mut7 heavy chain 9606
645 3A6C 2 H IG VH, anti-lysozyme 10090
646 2DQD 2 H Ig VH,anti-lysozyme 10090
647 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
648 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
649 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
650 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
651 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
652 1Q72 1 L Fab M82G2, Light chain 10090
653 1Q72 2 H Fab M82G2, Heavy chain 10090
654 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
655 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
656 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
657 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
658 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
659 4YHO 1 H aDabi-Fab3 heavy chain 9606
660 4YHO 2 L aDabi-Fab3 light chain 9606
661 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
662 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
663 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
664 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
665 4DGY 1 H HCV1 Heavy Chain Fab 9606
666 4DGY 2 L HCV1 Light Chain 9606
667 3A67 2 H IG VH, anti-lysozyme 10090
668 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
669 5EN2 1 A GD01 heavy chain 10090
670 5EN2 2 B GD01 light chain 10090
671 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
672 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
673 1J1X 2 H Ig VH,anti-lysozyme 10090
674 5M2J 2 D Anti-(ED-B) scFV 9606
675 3MXW 2 L 5E1 light chain 9606
676 3MXW 3 H 5E1 heavy chain 9606
677 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
678 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
679 2DQC 2 H Ig VH,anti-lysozyme 10090
680 1J1O 2 H Ig VH,anti-lysozyme 10090
681 3EO9 1 L Efalizumab Fab fragment, light chain 9606
682 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
683 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
684 4M62 2 H, I GEP2 FV heavy chain 9606
685 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
686 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
687 5IVO 1 A BC2-nanobody 30538
688 1J1P 2 H Ig VH,anti-lysozyme 10090
689 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
690 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
691 4NBZ 2 B, D A26.8 VHH 9844
692 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
693 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
694 5WUV 1 L light chain 9606
695 5WUV 2 H heavy chain 9606
696 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
697 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
698 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
699 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
700 5AYU 2 H Ig VH,anti-lysozyme 10090
701 4JM4 1 H PGT 135 Heavy Chain Fab 9606
702 4JM4 2 L PGT 135 Light Chain Fab 9606
703 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
704 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
705 3A6B 2 H IG VH, anti-lysozyme 10090
706 2DQJ 2 H Ig VH,anti-lysozyme 10090
707 5F21 2 B nanobody MU375 9844
708 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
709 6B0G 1 C 1245 Antibody, Light Chain 9606
710 6B0G 2 D 1245 Antibody, Heavy Chain 9606
711 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
712 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
713 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
714 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
715 2P44 2 B ANTIBODY CAB-RN05 9838
716 6BE4 1 H Fab (F598) Heavy Chain 9606
717 6BE4 2 L Fab(F598) Light Chain 9606
718 5TPP 1 L DH270.5 Fab heavy chain 9606
719 5TPP 2 H DH270.5 Fab light chain 9606
720 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
721 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
722 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
723 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
724 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
725 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
726 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
727 5TP3 1 A, B F-VHH-4 9844
728 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
729 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
730 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
731 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
732 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
733 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
734 5TL5 1 L M2177 LIGHT CHAIN 10090
735 5TL5 2 H M2177 HEAVY CHAIN 10090
736 2FX7 1 L Fab 4E10 Light Chain 9606
737 2FX7 2 H Fab 4E10 Heavy Chain 9606
738 5Y9K 1 L belimumab light chain 9606
739 5Y9K 2 H belimumab heavy chain 9606
740 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
741 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
742 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
743 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
744 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
745 4LHJ 2 B Camelid antibody 30538
746 3WFH 1 A mAb Fab H fragment 10090
747 3WFH 2 B mAb Fab L fragment 10090
748 4BEL 2 D, E XA4813 9844
749 5M7Q 1 A, B Nanobody NbD2 9838
750 5H8D 1 A VHH nanobody 9844
751 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
752 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
753 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
754 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
755 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
756 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
757 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
758 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
759 3DUR 2 B, D Ig-like protein 10090
760 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
761 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
762 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
763 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
764 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
765 5HI4 3 D, L CAT-2000 FAB light chain 9606
766 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
767 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
768 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
769 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
770 3RVW 2 C 4C1 - light chain 10090
771 3RVW 3 D 4C1 - heavy chain 10090
772 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
773 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
774 5XKU 2 B HNIgGA6 light chain 9606
775 5XKU 3 C HNIgGA6 heavy chain 9606
776 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
777 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
778 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
779 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
780 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
781 5HI5 3 D, L CAT-2000 light chain 9606
782 5JO5 1 A, C, E, H 10E8 gHV 9606
783 5JO5 2 B, D, F, L 10E8 gLV 9606
784 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
785 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
786 2XV6 2 B, D CAMELID VHH 9 30538
787 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
788 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
789 5CCK 2 L Antibody 3BC315 Fab light chain 9606
790 5VM0 1 A, B Camelid Nanobody VHH T9 9844
791 5I76 1 A, C FM318_light_chain 1383439
792 5I76 2 B, D FM318_heavy_cahin 1383439
793 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
794 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
795 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
796 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
797 5I18 1 L FAB LIGHT CHAIN 9606
798 5I18 2 H FAB HEAVY CHAIN 9606
799 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
800 4JN1 2 L anti-dabigatran Fab1, light chain 10090
801 4ZG1 1 A, B, C, D, E, F NB17 9844
802 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
803 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
804 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
805 4G5Z 2 L canakinumab antibody fragment light chain 9606
806 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
807 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
808 2OK0 2 L Fab ED10 light chain 10090
809 2OK0 3 H Fab ED10 heavy chain 10090
810 3SOB 1 L antibody light chain 9606
811 3SOB 3 H antibody heavy chain 9606
812 6B5M 1 H CIS43 Fab Heavy chain 9606
813 6B5M 2 L CIS43 Fab Light chain 9606
814 4I1N 2 B Protein ca1697 (nanobody) 9844
815 5AWN 1 H Heavy chain of 3BC176 Fab 9606
816 5AWN 2 L Light chain of 3BC176 Fab 9606
817 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
818 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
819 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
820 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
821 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
822 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
823 5DR5 2 L AbD09097 Fab light chain 9606
824 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
825 2IH3 1 A FAB Heavy Chain 10090
826 2IH3 2 B FAB Light Chain 10090
827 4KQ3 1 L CNTO3186 light chain Fab 9606
828 4KQ3 2 H CNTO3186 heavy chain Fab 9606
829 6F0D 1 A, B VHH antibody BCD090-M2 9844
830 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
831 6AQ7 3 L POM6 FAB light CHAIN 10090
832 4JFX 1 A, L Fab light chain 9606
833 4JFX 2 B, H Fab heavy chain 9606
834 3SGE 1 I, L Light Chain 10090
835 3SGE 2 H, J Heavy Chain 10090
836 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
837 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
838 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
839 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
840 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
841 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
842 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
843 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
844 5FHB 1 H Antibody 100 Fab heavy chain 9606
845 5FHB 2 L Antibody 100 Fab light chain 9606
846 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
847 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
848 1JGU 1 L Antibody Light Chain 10090
849 1JGU 2 H Antibody Heavy Chain 10090
850 4I77 1 H Lebrikizumab heavy chain Fab 9606
851 4I77 2 L Lebrikizumab light chain Fab 9606
852 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
853 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
854 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
855 4O4Y 2 H 2095-2 heavy chain 9986
856 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
857 5OBF 1 H fAb Heavy chain 10090
858 5OBF 2 L fAb Light chain 10090
859 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
860 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
861 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
862 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
863 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
864 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
865 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
866 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
867 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
868 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
869 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
870 4GLR 3 I, K anti-ptau light chain light chain 9031
871 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
872 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
873 4HJG 1 A Trastuzumab light chain 9606
874 4HJG 2 B Trastuzumab heavy chain 9606
875 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
876 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
877 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
878 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
879 5I30 1 L Fab PL-2 light chain 10090
880 5I30 2 H Fab PL-2 heavy chain 10090
881 4W6X 2 B Nanobody NbFedF7 9844
882 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
883 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
884 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
885 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
886 3FN0 1 L Fab Z13e1 light chain 9606
887 3FN0 2 H Fab Z13e1 heavy chain 9606
888 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
889 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
890 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
891 4YHI 2 B, L aDabi-Fab2a light chain 9606
892 4OSU 1 H SM5-1 Fab Heavy Chain 9606
893 4OSU 2 L SM5-1 Fab Light Chain 9606
894 5JA9 2 A, B Nanobody 6 9844
895 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
896 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
897 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
898 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
899 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
900 1T2Q 1 L Fab NNA7 Heavy Chain 10090
901 1T2Q 2 H Fab NNA7 Light Chain 10090
902 6ELJ 1 A, H fAB heavy chain 9606
903 6ELJ 2 B, L fAB light chain 9606
904 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
905 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
906 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
907 4MAU 1 L C2244 light chain SEE REMARK 999 10090
908 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
909 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
910 3LEX 2 B, L 11f10 Antibody Light Chain 10090
911 6B0W 1 L 1710 antibody, light chain 9606
912 6B0W 2 H 1710 antibody, heavy chain 9606
913 1OP3 1 K, L FAB 2G12, light chain light chain 9606
914 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606
915 1OP9 1 A HL6 camel VHH fragment 9838
916 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
917 5VH4 2 B, L Infliximab Fab Light Chain 10090
918 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
919 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
920 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
921 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
922 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
923 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
924 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
925 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
926 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
927 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
928 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
929 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
930 4LRN 1 H GEP 1 heavy chain 9606
931 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
932 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
933 4S11 1 A GELSOLIN NANOBODY 9844
934 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
935 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
936 3S96 1 A, C 3B5H10 FAB heavy chain 10090
937 3S96 2 B, D 3B5H10 FAB light chain 10090
938 4WEN 2 B Anti-F4+ETEC bacteria VHH variable region 9844
939 2YC1 1 A, D SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN 9606
940 5HGG 2 S, T Camelid Derived Antibody Fragment, Nb4 30538
941 4LKX 1 A Fab fragment heavy chain 9606
942 4LKX 2 B Fab fragment light chain 9606
943 1Q9O